SMC
FSTX

S. Muoio & Co’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

S. Muoio & Co’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$205K Buy
+40,000
New +$251K 0.27% 57

Other funds holding FSTX

RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

S. Muoio & Co's FSTX Position: Q3 2022 in Review

S. Muoio & Co opened a new position in F-star Therapeutics, Inc. Common Stock (FSTX) in Q3 2022: 40,000 shares worth $205K. The stake represents 0.27% of the portfolio and ranks #57 among its holdings.

54 funds tracked by Wall St. Rank hold FSTX as of Q3 2022.

  • S. Muoio & Co held 40,000 shares of F-star Therapeutics, Inc. Common Stock worth $205K as of Q3 2022.
  • F-star Therapeutics, Inc. Common Stock was a new S. Muoio & Co position in Q3 2022.
  • F-star Therapeutics, Inc. Common Stock made up 0.27% of S. Muoio & Co's portfolio in Q3 2022, its #57 holding.
  • 54 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q3 2022.

Based on S. Muoio & Co's 13F filing for Q3 2022, filed 14 Nov 2022.